Rationale and design of a randomised phase III registration trial investigating finerenone in participants with type 1 diabetes and chronic kidney disease: The FINE-ONE trial

PLS Type 1 diabetes is a condition where people have high blood sugar due to insufficient production of a protein called insulin. People with type 1 diabetes can often develop kidney disease. Eventually, their kidneys may stop working, resulting in the need for a procedure called dialysis which remo...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Diabetes research and clinical practice 2023-10, Vol.204, p.110908-110908, Article 110908
Hauptverfasser:	Heerspink, Hiddo J.L., Birkenfeld, Andreas L., Cherney, David Z.I., Colhoun, Helen M., Ji, Linong, Mathieu, Chantal, Groop, Per-Henrik, Pratley, Richard E., Rosas, Sylvia E., Rossing, Peter, Skyler, Jay S., Tuttle, Katherine R., Lawatscheck, Robert, Scott, Charlie, Edfors, Robert, Scheerer, Markus F., Kolkhof, Peter, McGill, Janet B.
Format:	Artikel
Sprache:	eng
Schlagworte:	Albuminuria Chronic kidney disease Finerenone Type 1 diabetes
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!